Glycogen phosphorylase inhibitors
US5998463A · kind A · utility
42Cited by
0References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 16, 1999 |
| Grant date | Dec 7, 1999 |
| Priority date | — |
| Expiry date | Feb 16, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D209/34
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to certain 5-acyl-2-oxo-indole-3-carboxamides useful as inhibitors of glycogen phosphorylase, methods of treating glycogen phosphorylase dependent diseases or conditions with such compounds and pharmaceutical compositions comprising such compounds. This invention also relates to pharmaceutical compositions comprising those 5-acyl-2-oxo-indole-3-carboxamides in combination with antidiabetes agents and methods of treating glycogen phosphorylase dependent diseases or conditions with such compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.